Administration of Interleukin-35-Conditioned Autologous Tolerogenic Dendritic Cells Prolong Allograft Survival After Heart Transplantation
Background/Aims: IL-35, a powerful suppressor of inflammation and autoimmunity, is primarily secreted by regulatory T cells (Tregs) and can, in turn, promote Treg differentiation. However, the precise effect of IL-35 on dendritic cells (DCs) remains to be clarified. Methods: In this study, we invest...
Main Authors: | Xianglan Liu, Yong Sun, Yang Zheng, Maomao Zhang, Xiangyuan Jin, Kai Kang, Yongshun Wang, Shuang Li, Hanlu Zhang, Qi Zhao, Shengnan Zhang, Jian Wu, Bo Yu |
---|---|
Format: | Article |
Language: | English |
Published: |
Cell Physiol Biochem Press GmbH & Co KG
2018-09-01
|
Series: | Cellular Physiology and Biochemistry |
Subjects: | |
Online Access: | https://www.karger.com/Article/FullText/493298 |
Similar Items
-
The Long Noncoding RNA MALAT1 Induces Tolerogenic Dendritic Cells and Regulatory T Cells via miR155/Dendritic Cell-Specific Intercellular Adhesion Molecule-3 Grabbing Nonintegrin/IL10 Axis
by: Jian Wu, et al.
Published: (2018-08-01) -
Corrigendum: The Long Noncoding RNA MALAT1 Induces Tolerogenic Dendritic Cells and Regulatory T Cells via miR155/Dendritic Cell-Specific Intercellular Adhesion Molecule-3 Grabbing Nonintegrin/IL10 Axis
by: Jian Wu, et al.
Published: (2020-10-01) -
Tolerogenic Dendritic Cells: The Pearl of Immunotherapy in Organ Transplantation
by: Quan Zhuang, et al.
Published: (2020-10-01) -
Tolerogenic Dendritic Cell-Based Approaches in Autoimmunity
by: Laura Passeri, et al.
Published: (2021-08-01) -
Expression of tolerogenic potential-representing markers on clinical-grade therapeutic dendritic cell-based cancer vaccines
by: Neringa T. Dobrovolskienė, et al.
Published: (2014-02-01)